New screening approach targets lung cancer in asian women who never smoked

NCT ID NCT05164757

Ongoing Diagnosis Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study aims to improve early detection of lung cancer in Asian women who have never smoked, a group at higher risk but not covered by standard screening guidelines. Participants receive up to three low-dose CT scans and a blood test designed to spot early signs of cancer. Researchers also collect health and exposure information to better understand risk factors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: low-dose CT scan and blood-based assay
What this could lead to: If successful, this could lead to better early detection of lung cancer in Asian female never smokers, potentially saving lives by catching the disease earlier.
What could go wrong: This is an observational screening study, not a treatment trial. The blood test may not prove accurate enough for widespread use, and false positives could cause unnecessary worry or procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

NYU Langone Health

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.